Muge Cevik, MD, MSc, MRCP(UK) is a clinician scientist in infectious diseases and medical virology. Her research interests focus on HIV, tuberculosis, other tropical infections and emerging infections including Covid-19 since the beginning of 2020.
During the Covid-19 pandemic, as well as working on the NHS front line of the response, Muge provided scientific advice to the Chief Medical Officer – Scotland and advisory groups on recent scientific developments on Covid-19. She has been co-opted to NERVTAG (New and Emerging Respiratory Virus Threats Advisory Group) as a member for Covid-19, advising and producing guidance documents for UK-SAGE (Scientific Advisory Group for Emergencies). She also provided advice and consultancy to the World Health Organisation (WHO) on risk communication during Covid-19 pandemic.
Muge is also coordinating the recruitment of hospitalised COVID-19 patients in South East Asia and South Africa working closely with the International Severe Acute Respiratory and Emerging Infections Consortium (ISARIC). Additionally, she is co-leading a household transmission study in Scotland as well as a prospective study to quantify the burden of Covid-19 in patients with tuberculosis in Kampala, Uganda. She is part of the CORRE Network (Covid-19 International Rapid Evidence Reviews Group) working towards providing rapid reviews for governments and the WHO.
Muge obtained her MD from the Ege University School of Medicine and MSc from the London School of Hygiene and Tropical Medicine. She has been awarded CSO Clinical Academic Fellowship to study the impact of type 2 diabetes on severity of pulmonary tuberculosis and treatment outcomes in Uganda.